Literature DB >> 2873408

Nosocomial outbreak of Campylobacter jejuni meningitis in newborn infants.

H Goossens, G Henocque, L Kremp, J Rocque, R Boury, G Alanio, L Vlaes, W Hemelhof, C Van den Borre, M Macart.   

Abstract

In a nosocomial outbreak of Campylobacter jejuni infection 11 newborn infants (7 female, 4 male) had meningitis. The outbreak was caused by a single strain of C jejuni, as demonstrated by biotyping (biotype I), serotyping (LAU 7/PEN 18 on heat-stable antigens, a new serotype on heat-labile antigens), and the identical susceptibility pattern and outer-membrane-protein profile on sodium dodecyl sulphate/polyacrylamide gel electrophoresis. Specific antibodies against the outbreak strain (enzyme-linked immunosorbent assay and Western blot) developed in all the babies. They were treated with gentamicin and ampicillin. All but one baby, who had a moderately dilated left lateral ventricle after the meningitis, recovered well. The source of infection could not be clearly determined. Thus, C jejuni can cause serious nosocomial infection; it should be considered as a possible agent of meningitis of unknown origin, particularly in newborn infants and other compromised hosts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873408     DOI: 10.1016/s0140-6736(86)91956-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

Review 1.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

2.  Nosocomial meningitis due to Campylobacter fetus subsp. fetus in a neonatal intensive care unit.

Authors:  T Morooka; H Takeo; S Takeshita; T Mimatsu; K Yukitake; T Oda
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

3.  Rapid detection of Campylobacter jejuni in stool specimens by an enzyme immunoassay and surveillance for Campylobacter upsaliensis in the greater Salt Lake City area.

Authors:  M Hindiyeh; S Jense; S Hohmann; H Benett; C Edwards; W Aldeen; A Croft; J Daly; S Mottice; K C Carroll
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

4.  Early onset neonatal sepsis with Campylobacter jejuni: a case report.

Authors:  R Krishnaswamy; P Sasidharan; A Rejjal; Y A Osba
Journal:  Eur J Pediatr       Date:  1991-02       Impact factor: 3.183

5.  Molecular characterization of invasive and noninvasive Campylobacter jejuni and Campylobacter coli isolates.

Authors:  A C Carvalho; G M Ruiz-Palacios; P Ramos-Cervantes; L E Cervantes; X Jiang; L K Pickering
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

6.  Iron-responsive genetic regulation in Campylobacter jejuni: cloning and characterization of a fur homolog.

Authors:  K G Wooldridge; P H Williams; J M Ketley
Journal:  J Bacteriol       Date:  1994-09       Impact factor: 3.490

7.  Molecular typing of Campylobacter jejuni isolates involved in a neonatal outbreak indicates nosocomial transmission.

Authors:  José Llovo; Estíbaliz Mateo; Angeles Muñoz; María Urquijo; Stephen L W On; Aurora Fernández-Astorga
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

8.  Significant contribution of the CmeABC Efflux pump in high-level resistance to ciprofloxacin and tetracycline in Campylobacter jejuni and Campylobacter coli clinical isolates.

Authors:  Saeed Sharifi; Bita Bakhshi; Shahin Najar-Peerayeh
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-05-20       Impact factor: 3.944

Review 9.  Polyphosphate and associated enzymes as global regulators of stress response and virulence in Campylobacter jejuni.

Authors:  Anand Kumar; Dharanesh Gangaiah; Jordi B Torrelles; Gireesh Rajashekara
Journal:  World J Gastroenterol       Date:  2016-09-07       Impact factor: 5.742

Review 10.  The Clinical Importance of Campylobacter concisus and Other Human Hosted Campylobacter Species.

Authors:  Fang Liu; Rena Ma; Yiming Wang; Li Zhang
Journal:  Front Cell Infect Microbiol       Date:  2018-07-24       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.